ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $120,000 | +700.0% | 82,697 | +678.8% | 0.01% | +400.0% |
Q4 2016 | $15,000 | -59.5% | 10,618 | -50.9% | 0.00% | -66.7% |
Q3 2016 | $37,000 | +12.1% | 21,641 | +11.7% | 0.00% | +50.0% |
Q2 2016 | $33,000 | -5.7% | 19,366 | +8.2% | 0.00% | -33.3% |
Q1 2016 | $35,000 | +34.6% | 17,892 | +28.8% | 0.00% | +50.0% |
Q4 2015 | $26,000 | +1200.0% | 13,892 | +1017.6% | 0.00% | – |
Q3 2015 | $2,000 | – | 1,243 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |